Synapse Open Synapse
Biology

Pfizer’s eczema drug clears skin in mid-stage trial

BioPharma Dive · · 3 min read

Detailed results are competitive with Dupixent and Ebglyss, but the drug lacks differentiation amid an increasingly competitive landscape, one analyst argued.

Latest from BioPharma Dive